Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study

NCT07017426 is registered in ClinicalTrials.gov with Zhiyun Yang as lead sponsor.

NCT NCT07017426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07017426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fuzheng Huayu Tablets Reduce the Occurrence of Re-Decompensation Events in Patients With First Decompensation of Hepatitis B-Related Liver Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Lead sponsor
Zhiyun Yang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2027
Enrollment
432 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

decompensated hepatitis b cirrhosis